Godfroid Jacques, Nielsen Klaus, Saegerman Claude
Section of Arctic Veterinary Medicine, Department of Food Safety and Infection Biology, Norwegian School of Veterinary Science, Stakkevollveien 2, 9010 Tromso, Norway.
Croat Med J. 2010 Aug;51(4):296-305. doi: 10.3325/cmj.2010.51.296.
To describe and discuss the merits of various direct and indirect methods applied in vitro (mainly on blood or milk) or in vivo (allergic test) for the diagnosis of brucellosis in animals.
The recent literature on brucellosis diagnostic tests was reviewed. These diagnostic tests are applied with different goals, such as national screening, confirmatory diagnosis, certification, and international trade. The validation of such diagnostic tests is still an issue, particularly in wildlife. The choice of the testing strategy depends on the prevailing brucellosis epidemiological situation and the goal of testing.
Measuring the kinetics of antibody production after Brucella spp. infection is essential for analyzing serological results correctly and may help to predict abortion. Indirect ELISAs help to discriminate 1) between false positive serological reactions and true brucellosis and 2) between vaccination and infection. Biotyping of Brucella spp. provides valuable epidemiological information that allows tracing an infection back to the sources in instances where several biotypes of a given Brucella species are circulating. Polymerase chain reaction and new molecular methods are likely to be used as routine typing and fingerprinting methods in the coming years.
The diagnosis of brucellosis in livestock and wildlife is complex and serological results need to be carefully analyzed. The B. abortus S19 and B. melitensis Rev. 1 vaccines are the cornerstones of control programs in cattle and small ruminants, respectively. There is no vaccine available for pigs or for wildlife. In the absence of a human brucellosis vaccine, prevention of human brucellosis depends on the control of the disease in animals.
描述并讨论应用于体外(主要针对血液或乳汁)或体内(变态反应试验)诊断动物布鲁氏菌病的各种直接和间接方法的优点。
回顾了近期有关布鲁氏菌病诊断试验的文献。这些诊断试验应用于不同目标,如国家筛查、确诊诊断、认证及国际贸易。此类诊断试验的验证仍是一个问题,尤其是在野生动物方面。检测策略的选择取决于当地布鲁氏菌病的流行情况和检测目标。
测定布鲁氏菌属感染后抗体产生的动力学对于正确分析血清学结果至关重要,且可能有助于预测流产。间接酶联免疫吸附测定有助于区分:1)假阳性血清学反应与真正的布鲁氏菌病;2)疫苗接种与感染。布鲁氏菌属的生物分型提供了有价值的流行病学信息,在某一特定布鲁氏菌物种的几种生物型流行的情况下,可据此将感染追溯至源头。聚合酶链反应和新的分子方法在未来几年可能会用作常规分型和指纹识别方法。
家畜和野生动物布鲁氏菌病的诊断较为复杂,血清学结果需仔细分析。牛流产布氏杆菌S19疫苗和羊种布氏杆菌Rev.1疫苗分别是牛和小反刍动物防控计划的基石。目前尚无猪或野生动物可用的疫苗。在没有人类布鲁氏菌病疫苗的情况下,预防人类布鲁氏菌病取决于对动物疾病的控制。